UY26206A1 - IL-8 RECEPTOR ANTAGONISTS. - Google Patents

IL-8 RECEPTOR ANTAGONISTS.

Info

Publication number
UY26206A1
UY26206A1 UY26206A UY26206A UY26206A1 UY 26206 A1 UY26206 A1 UY 26206A1 UY 26206 A UY26206 A UY 26206A UY 26206 A UY26206 A UY 26206A UY 26206 A1 UY26206 A1 UY 26206A1
Authority
UY
Uruguay
Prior art keywords
receptor antagonists
treatment
relates
disease states
mediated disease
Prior art date
Application number
UY26206A
Other languages
Spanish (es)
Inventor
Katherine L Widdowson Y Benson
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc
Publication of UY26206A1 publication Critical patent/UY26206A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Esta invención se refiere a nuevas fenil-ureas útiles en el tratamiento de estados de enfermedad mediados por la quimiocina interleucina-8 (IL-8)This invention relates to novel phenyl ureas useful in the treatment of chemokine interleukin-8 (IL-8) mediated disease states.

UY26206A 1999-06-16 2000-06-13 IL-8 RECEPTOR ANTAGONISTS. UY26206A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13967399P 1999-06-16 1999-06-16

Publications (1)

Publication Number Publication Date
UY26206A1 true UY26206A1 (en) 2000-12-29

Family

ID=22487779

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26206A UY26206A1 (en) 1999-06-16 2000-06-13 IL-8 RECEPTOR ANTAGONISTS.

Country Status (20)

Country Link
EP (1) EP1185271A4 (en)
JP (1) JP2003501470A (en)
KR (1) KR20020012275A (en)
CN (1) CN1356902A (en)
AR (1) AR024349A1 (en)
AU (1) AU767000B2 (en)
BR (1) BR0011567A (en)
CA (1) CA2377391A1 (en)
CO (1) CO5190709A1 (en)
CZ (1) CZ20014491A3 (en)
HU (1) HUP0202004A3 (en)
IL (1) IL146515A0 (en)
MX (1) MXPA01013089A (en)
NO (1) NO20016102L (en)
NZ (1) NZ515609A (en)
PL (1) PL352222A1 (en)
TR (1) TR200103608T2 (en)
UY (1) UY26206A1 (en)
WO (1) WO2000076515A1 (en)
ZA (1) ZA200110205B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0704651D0 (en) * 2007-03-09 2007-04-18 Ucl Business Plc Composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2060682T3 (en) * 1988-03-30 1994-12-01 Warner Lambert Co N - ((FENIL (2,6-DISUBSTITUTED)) - N'-ARIL) UREAS AS ANTI-HYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS.
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
JP2001512096A (en) * 1997-07-29 2001-08-21 スミスクライン・ビーチャム・コーポレイション IL-8 receptor antagonist

Also Published As

Publication number Publication date
AU767000B2 (en) 2003-10-30
PL352222A1 (en) 2003-08-11
MXPA01013089A (en) 2002-06-04
IL146515A0 (en) 2002-07-25
JP2003501470A (en) 2003-01-14
EP1185271A1 (en) 2002-03-13
BR0011567A (en) 2002-03-05
HUP0202004A3 (en) 2003-03-28
NO20016102L (en) 2002-02-12
WO2000076515A1 (en) 2000-12-21
CO5190709A1 (en) 2002-08-29
AU5875000A (en) 2001-01-02
TR200103608T2 (en) 2002-06-21
CA2377391A1 (en) 2000-12-21
ZA200110205B (en) 2002-08-12
EP1185271A4 (en) 2004-02-04
HUP0202004A2 (en) 2002-10-28
CZ20014491A3 (en) 2002-07-17
NO20016102D0 (en) 2001-12-14
CN1356902A (en) 2002-07-03
KR20020012275A (en) 2002-02-15
NZ515609A (en) 2003-11-28
AR024349A1 (en) 2002-10-02

Similar Documents

Publication Publication Date Title
ATE419845T1 (en) IL-8 RECEPTOR ANTAGONISTS
TR200101772T2 (en) Hydroxy diphenyl urea sulfonamides as IL-8 Receptor antagonists
NO986110L (en) IL-8 receptor antagonists
CY1106514T1 (en) IL-8 RECEPTOR ANTAGONISTS
SMP200600024B (en) 2,6-Biseteroaryl-4-aminopirimidine as adenosine receptor antagonists
TR199900318T2 (en) IL-8 receptor antagonists.
UY26601A1 (en) IL-8 RECEPTOR ANTAGONISTS
ATE424194T1 (en) ADENOSINE A2A RECEPTOR ANTAGONISTS IN COMBINATION WITH COMPOUNDS WITH NEUROTROPHIC ACTIVITY IN THE TREATMENT OF PARKINSON&#39;S DISEASE
AP1548A (en) Il-8 Receptor Antagonists.
WO2005000231A3 (en) Il-8 receptor antagonists
WO2001068569A3 (en) Il-8 receptor antagonists
BR0010843A (en) Il-8 receptor antagonists
AR024350A1 (en) ANTAGONISTS OF IL-8 RECEIVERS
WO2000072800A3 (en) Il-8 receptor antagonists
UY26206A1 (en) IL-8 RECEPTOR ANTAGONISTS.
MY143477A (en) Il-8 receptor antagonists
BR0010863A (en) Il-8 receptor antagonists
ECSP003525A (en) IL-8 IV RECEIVER ANTAGONISTS
AP2002002606A0 (en) IL-8 receptor antagonists.
WO2001064165A3 (en) Il-8 receptor antagonists
WO2001076530A3 (en) Il-8 receptor antagonists
ECSP003527A (en) IL RECEIVER ANTAGONISTS - 8 V
WO2001068033A3 (en) Il-8 receptor antagonists
ECSP003529A (en) ANTAGONISTS OF THE RECEIVER OF IL - 8 VII
BR0214613A (en) N-ureide piperidines as ccr-3 receptor antagonists

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20100520